A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.
about
Combining radiotherapy with sunitinib: lessons (to be) learnedStereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancerMicroRNA expression characterizes oligometastasis(es)Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAsStereotactic Body Radiotherapy in the Management of Oligometastatic DiseaseGastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation TherapyPhase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastasesQuality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summaryNormal tissue toxicity after small field hypofractionated stereotactic body radiation.A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results.Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects.Robotic stereotactic body radiation therapy for liver-limited malignant tumorsConcurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial.Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancerPhase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation OncologyMulticentre results of stereotactic body radiotherapy for secondary liver tumours.Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancerDoes Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer.Competing Risk Analysis of Neurologic versus Nonneurologic Death in Patients Undergoing Radiosurgical Salvage After Whole-Brain Radiation Therapy Failure: Who Actually Dies of Their Brain Metastases?Clinical outcomes of stereotactic body radiotherapy for patients with lung tumors in the state of oligo-recurrence.Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease.Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort studyHypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy.Carbon ion radiotherapy for oligo-recurrence in the lung.Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy.Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of MetastasisClinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach.Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma.Stereotactic body radiation therapy for oligometastases.Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments.A contemporary review of stereotactic radiotherapy: inherent dosimetric complexities and the potential for detriment.Management of isolated Adrenal Lesions in Cancer Patients.Multidisciplinary approach of colorectal liver metastases.
P2860
Q26800587-9F6624F0-9DB4-4884-B04A-AF746DEA137FQ26866335-CCA926DF-DE6F-4699-8B0D-10F104BB985CQ27311314-457BA8DE-9D83-4685-B164-6BD58E6BCB4AQ27334649-A9383052-F2FB-41F4-8A99-3169B5496BA1Q28071733-5B46771E-BB4B-45DB-85EC-0A0A6E7C879BQ28086904-ECDF4F88-0896-40B0-9234-93CCAAE85BE1Q28727917-832AAE83-218D-4A83-9079-655CC336063DQ30416741-BD8B15FB-0580-4B75-AE2F-99C55AAB0FAEQ30484881-8B469517-979C-4995-BE57-CB3E3368AE69Q32173730-FD382EA2-C384-4375-BD95-D804F34E8F93Q33823590-37C16792-80A8-437F-9512-6A6AFD535198Q34002010-55E15067-A075-4331-AC26-CB94FF173E22Q34196471-9295DC81-4E6C-4012-8672-D027A709D7D2Q34304095-AD8AEC24-0F24-431F-8173-BA4100D1735BQ34791775-E2BE712C-62AF-4CB7-B78C-754765E33CF4Q35117298-076C4896-F164-47CB-AC66-7A8CC5DAA6BDQ35121736-E415AFE3-A39C-4B03-8288-18BA966B3AAAQ35207748-53D0F9BF-2E9F-4C16-BB35-A5D3934E2CBDQ35496632-3E2959D5-20BB-4DF2-81B6-C1B77D94CCADQ35854741-1A65F171-5DE9-4F2D-8888-1F73EE9D002CQ35968430-AEB3698A-B970-4E46-A0D6-CA4D430F5903Q35976055-CCD887A0-B4F2-4B9A-95A3-9AD73EC3A36FQ35981775-9A313465-389D-4554-806F-63E643715D85Q36101987-F1EC70EB-6DC2-4E25-B4CD-B40C571406E5Q36295437-7A44FB09-83DB-4E35-972A-7D835A92FCA4Q36422709-650331B0-7F71-41FC-B9C2-CF33E641003BQ36507559-7068CCE1-A610-45C4-8A1D-CABA36BE4530Q36552769-39D0A540-0ADF-4AAC-9102-768FB857862EQ36555940-E7361A9A-5F82-4228-BEA3-DEE320D891E8Q36599965-F23B8098-8891-4E2D-8C22-223D8A41DC7BQ36661444-051D03D3-7DA9-4155-8DBE-8CB0E4B94235Q37011155-3F814425-3C26-4F4C-83D2-EE5C642BAD56Q37187233-6C9D6AF1-17CF-4541-8FC7-391BF19703E8Q37254116-2407F2DB-EC86-4481-8B82-784D654DD11BQ37483976-34D42A7F-AAF5-4979-9DE0-E5BD4C881071Q37618671-370FE1FE-80DD-4C8D-B876-465653B4B83EQ37723610-920E6431-69B0-474C-8EC3-8915DEFC931FQ37834640-FAB87C54-B4B5-499D-BEE1-78FE3426E527Q37859614-62A3EEB6-E095-4E7E-945C-F4756AC7DA16Q37942736-E9023467-6813-4786-B7DE-0CE0A73CBF41
P2860
A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A prospective pilot study of c ...... fewer oligometastatic lesions.
@ast
A prospective pilot study of c ...... fewer oligometastatic lesions.
@en
A prospective pilot study of c ...... fewer oligometastatic lesions.
@nl
type
label
A prospective pilot study of c ...... fewer oligometastatic lesions.
@ast
A prospective pilot study of c ...... fewer oligometastatic lesions.
@en
A prospective pilot study of c ...... fewer oligometastatic lesions.
@nl
prefLabel
A prospective pilot study of c ...... fewer oligometastatic lesions.
@ast
A prospective pilot study of c ...... fewer oligometastatic lesions.
@en
A prospective pilot study of c ...... fewer oligometastatic lesions.
@nl
P2093
P356
P1433
P1476
A prospective pilot study of c ...... fewer oligometastatic lesions.
@en
P2093
Abraham Philip
Alan W Katz
Ann G Muhs
Daniel J Buchholz
Michael C Schell
Michael T Milano
Paul Okunieff
P304
P356
10.1002/CNCR.23209
P407
P577
2008-02-01T00:00:00Z